The FDA has given Bayer approval for the Betaconnect electronic autoinjector and its companion app, myBETAapp, for use in patients with multiple sclerosis. The autoinjector facilitates administration of Betaseron, while the app allows data access and sharing between patients and health care professionals because it connects with the autoinjector via Bluetooth technology.
FDA OKs Bayer's Betaseron autoinjector, companion app
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.